Business News

DRL, Emcure get approval to make breakthrough HIV drug

FinSiddhi

India’s drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for local clinical trials. This move will improve access to the HIV prevention injection. Lenacapavir is a breakthrough twice-yearly injection for HIV prevention. Patient groups had urged the regulator to expedite this process.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

‘Why is she wearing shorts’: How family outing at Pune fort turned into assault

Police registered a case against eight right-wing outfit members after an assault. The incident occurred at Sinhagad Fort following an argument over a girl’s attire. The group allegedly questioned and then physically assaulted the complainant and his family. Similar complaints were also received from other visitors to the historical fort. Authorities have launched a search…

Global Market: China’s factory inflation hits four-year high, keeping metals and industrial stocks in focus

China’s factory-gate inflation reached its fastest pace in four years during June. Producer prices rose 4.1 percent year-on-year, driven by energy and commodity costs. However, consumer inflation slowed to 1.0 percent, reflecting weak domestic demand. Manufacturers face rising costs but struggle to pass them onto consumers. This uneven recovery highlights export strength against domestic economic…